Eitan Group Opens New Office in Southern California, Embraces Burgeoning Local MedTech Community

NETANYA, Israel, June 4, 2019 /PRNewswire/ — Eitan Group, a global leader in advanced infusion therapy solutions across the care continuum, today announced the opening of a new office in Southern California. The new US Headquarters will be based in Aliso Viejo and will be led by Eitan Group North America CEO, Roger Massengale, to support purchasing, training and service-related needs.

“As we begin to jumpstart our U.S. operations, we felt it was crucial to establish ourselves in the fastest growing MedTech community in the U.S.,” said Roger Massengale, CEO of Eitan Group North America. “Eitan Group is the leader of innovation within the infusion market and is home to over 100 engineers who ensure that our advanced and intuitive systems, the flagship Sapphire infusion system, functions at a high level. We are excited to add local medtech talent to our ranks as we continue to innovate in our ongoing quest to provide world-class infusion therapy solutions.”

Southern California provides the highest level of employment to MedTech professionals according to U.S. Dept. of Commerce data. Including Los Angeles, Orange County, and San Diego, the area employs over 33,000 people, outpacing other MedTech hotbeds such as New York, Northern California, Minneapolis, and Boston.

Eitan Group companies Q Core Medical, Avoset Health and Sorrel Medical offer infusion therapy solutions to meet patient and provider needs in a variety of settings. Q Core provides its robust Sapphire system to the hospital and homecare markets; Sorrel Medical offers pharma partners a flexible wearable platform for new biologic drugs; Avoset Health will provide dedicated connected infusion solutions for the homecare market. 

About Eitan Group
Eitan Group is focused on infusion therapy and technologies, developing future-ready systems for hospital care and ambulatory settings, as well as wearable solutions for easy self-administration. Eitan Group initially entered the infusion market in 2009, and a decade later, with over 18 million liters of infusions completed, now consists of three affiliate companies: Q Core Medical, Sorrel Medical and Avoset Health. With a focus on innovating patient-centered care, and safety, the Eitan Group is reimagining infusion therapy with connected, software-based solutions.

Follow The Eitan Group on LinkedIn and Twitter.

Eitan Group Contact:
Roger Massengale
CEO Eitan Group North America
877-541-9944
CustomerserviceNA@eitangroup.com

Media Relations Contact:
Mordy Derovan
Finn Partners
929-222-8012
mordy.derovan@finnpartners.com

 

View original content:http://www.prnewswire.com/news-releases/eitan-group-opens-new-office-in-southern-california-embraces-burgeoning-local-medtech-community-300861450.html

SOURCE Eitan Group

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

19 hours ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

19 hours ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

19 hours ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

19 hours ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

19 hours ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

19 hours ago